P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Detalles Bibliográficos
Autores principales: Eshaghpour, Ali, Yu, Philip, Ge, Sarah, Kou, Roger, Loeb, Nathalie, Crowther, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430018/
http://dx.doi.org/10.1097/01.HS9.0000973276.11676.38
_version_ 1785090853192073216
author Eshaghpour, Ali
Yu, Philip
Ge, Sarah
Kou, Roger
Loeb, Nathalie
Crowther, Mark
author_facet Eshaghpour, Ali
Yu, Philip
Ge, Sarah
Kou, Roger
Loeb, Nathalie
Crowther, Mark
author_sort Eshaghpour, Ali
collection PubMed
description
format Online
Article
Text
id pubmed-10430018
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104300182023-08-17 P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS Eshaghpour, Ali Yu, Philip Ge, Sarah Kou, Roger Loeb, Nathalie Crowther, Mark Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430018/ http://dx.doi.org/10.1097/01.HS9.0000973276.11676.38 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Eshaghpour, Ali
Yu, Philip
Ge, Sarah
Kou, Roger
Loeb, Nathalie
Crowther, Mark
P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_full P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_fullStr P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_full_unstemmed P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_short P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_sort p1600: use of rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430018/
http://dx.doi.org/10.1097/01.HS9.0000973276.11676.38
work_keys_str_mv AT eshaghpourali p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis
AT yuphilip p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis
AT gesarah p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis
AT kouroger p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis
AT loebnathalie p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis
AT crowthermark p1600useofrituximabplusstandardofcarefortreatmentofprimaryimmunethrombocytopeniaasystematicreviewandmetaanalysis

Ejemplares similares